‌

US Patent 9388183 Heterocyclic compounds and uses thereof

Patent 9388183 was granted and assigned to Infinity Pharmaceuticals on July, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Infinity Pharmaceuticals

Current Assignee

Infinity Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Alfredo C. Castro0

Pingda Ren0

Troy Edward Wilson0

Yi Liu0

Catherine A. Evans0

Daniel A. Snyder0

Katrina Chan0

Liansheng Li0

Date of Patent

July 12, 2016

Patent Application Number

14512262

Date Filed

October 10, 2014

Patent Citations Received

US Patent 11939333 Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same

0

Patent Primary Examiner

Golam M. M. Shameem

Patent abstract

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9388183 Heterocyclic compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.